Evidence map›Paper›PMID 42387113›Full record

ReviewCerebellum (London, England)2026

Adult-Onset SCAR4 with a 30-Year Slowly Progressive Course: First Combined Assessment with FDG-PET and Brain Perfusion SPECT.

Ryunosuke Nagao, Kazuya Kawabata, Tamae Ohye, Naoko Ishihara, Yasuaki Mizutani, Hirohisa Watanabe

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryunosuke NagaoDepartment of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Kazuya KawabataDepartment of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Tamae OhyeDepartment of Clinical Genetics, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Naoko IshiharaDepartment of Clinical Genetics, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Yasuaki MizutaniDepartment of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan.
Hirohisa WatanabeDepartment of Neurology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan. hirohisa.watanabe@fujita-hu.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal recessive spinocerebellar ataxia type 4 (SCAR4), caused by biallelic vacuolar protein-sorting 13D (VPS13D) variants, is a rare, clinically heterogeneous disorder. To describe an adult-onset SCAR4 case with a 30-year course and compare its features to those of published cases. We analyzed the clinical and imaging findings of a 58‑year‑old man and performed a literature review with pooled analysis of reported VPS13D/SCAR4 cases. The patient developed gait disturbance in his twenties, followed by progressive cerebellar and sensory ataxia, pyramidal signs, and peripheral neuropathy. MRI showed mild cerebellar atrophy. Fluorodeoxyglucose positron emission tomography and brain perfusion single-photon emission computed tomography revealed slightly reduced signals in the anterior cerebellum. Whole-exome sequencing revealed compound heterozygous VPS13D variants, including a pathogenic frameshift and a likely pathogenic missense variant. A literature review identified 47 cases. SCAR4 should be considered in sporadic adults with cerebellar ataxia, pyramidal signs, and peripheral neuropathy.

Indexed as

BrainSpinocerebellar AtaxiasAge of OnsetDisease ProgressionFluorodeoxyglucose F18HumansMaleMiddle AgedPositron-Emission TomographyTomography, Emission-Computed, Single-PhotonFluorodeoxyglucose F18Autosomal recessive spinocerebellar ataxiaFDG-PETNovel variantSPECTVPS13D

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.